SEP 29, 2015 02:59 PM PDT

New Hybrid Chip to Diagnose Ebola

WRITTEN BY: Kerry Evans
Researchers at the University of California Santa Cruz want to make it easier to diagnose Ebola in the field, where few resources are available.  Current diagnostic tests for Ebola rely on PCR (polymerase chain reaction) which requires that the virus’s RNA first be reverse-transcribed into DNA, a process that requires laboratory space.  To simplify things, the group has developed a chip-based system that detects viral RNA.  
 
Hybrid chip technology could simplify Ebola diagnosis.

Ebola is a filovirus that was first isolated in Zaire.  (Incidentally, I just read Richard Preston’s The Hot Zone, which details the Ebola Reston outbreak in laboratory monkeys near Washington D.C.)  Filoviruses are shaped like long filaments and often have a loop, or “shepherd’s crook”, at one end.  The Ebola genome is a single strand of RNA, which codes for seven proteins.  The virus is transmissible through body fluids and causes a devastating hemorrhagic fever, characterized by bloody vomit and diarrhea.

The most recent Ebola outbreak began in West Africa in 2014, with some cases remaining in Sierra Leone and Guinea.  Since then, it has killed over 11,000 people.  In order to manage such outbreaks, healthcare workers must be able to efficiently and accurately diagnose Ebola infections.  

The UC Santa Cruz team, in collaboration with Brigham Young University, UC Berkeley, and the Texas Biomedical Research Institute in San Antonio, developed a hybrid microfluidic/optofluidic chip to diagnose Ebola.  The microfluidic chip is silicon-based and contains tiny channels that transport the sample.  The chip uses a synthetic oligonucleotide (DNA) attached to magnetic beads to trap viral RNA with a matching sequence.  The beads are trapped by a magnet, washed, and the RNAs are labeled with a fluorescent marker.  At this point, the sample makes its way to the optofluidic chip and the fluorescent signal is detected.  

There’s just one (temporary) drawback.  The team hasn’t been able to test their chip with actual blood samples containing Ebola, as this requires a level 4 biosafety lab.  However, the team hopes to soon check that off their list.  


Sources: UC Santa Cruz, CDC, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
SEP 30, 2018
Drug Discovery
SEP 30, 2018
Researchers Re-classify the 'Magic Mushroom' Drug
Researchers at John Hopkins have evaluated the safety and efficacy of compound, psilocybin, found in hallucinogenic mushrooms. They suggested that if evalu...
OCT 25, 2018
Microbiology
OCT 25, 2018
Common Herbicides Increase Antibiotic Resistance
If we have to feed a growing planet, it may hurt us in the long run if the methods used in farming are actually increasing antibiotic-resistance in bacteria....
NOV 01, 2018
Microbiology
NOV 01, 2018
Gut Bacteria can Have an Impact on Movement
One strain of gut bacteria can change how a fruit fly moves....
NOV 28, 2018
Cell & Molecular Biology
NOV 28, 2018
Microbes with an Expanded Genetic Code can Generate new Proteins with Special Properties
In recent years, scientists have created microbes that incorporate new nucleotide bases and new amino acids....
DEC 03, 2018
Microbiology
DEC 03, 2018
Finding Emerging Viruses
Scientists have developed a tool that enables them to predict what viruses be transmissible between infected people....
DEC 07, 2018
Microbiology
DEC 07, 2018
Epigenetic Inheritance is Revealed in Archaea
Researchers may have found a great new way to study tags that are added to the genome, which change how genes are expressed....
Loading Comments...